Cathy J. Walker R.D., L.D.N. - PowerPoint PPT Presentation

1 / 22
About This Presentation
Title:

Cathy J. Walker R.D., L.D.N.

Description:

Strong odor from Whey Protein. Approx. 75% of pts who tried the product used it successfully ... or NH placement, disliked odor/ taste, didn't want to use ... – PowerPoint PPT presentation

Number of Views:65
Avg rating:3.0/5.0
Slides: 23
Provided by: cathyw1
Category:
Tags: cathy | walker

less

Transcript and Presenter's Notes

Title: Cathy J. Walker R.D., L.D.N.


1
Protein Supplements in Renal Dialysis. Do they
Really Work?
  • Cathy J. Walker R.D., L.D.N.
  • Renal Dietitian
  • Provena St Marys Dialysis Centers
  • Kankakee, IL 815-937-3077

2
Our Ideal Renal Supplement
  • Maximum improvement in Albumin with minimal
    increase in Phosphorus
  • Protein without unnecessary Calories
  • Easy to use / Add to foods
  • Acceptable taste and texture
  • Affordable, covered by insurance

3
Right Place, Right Time?
  • Involved w/ Development of Protein Supplement
    specifically for Renal Pts.
  • Whey Protein Isolates
  • Calcium Caseinate (Phosphate binder)
  • Arginine
  • Carnitine

4
Albumax Information
  • 1 serving / scoop is one Tablespoon
  • 125 scoops per container
  • Low in Na, K, P and Ca
  • www.albumax.com

5
Full Disclosure
  • Theoretically, I stand to gain financially from
    the Sale of Albumax
  • Involved in the design of the product
  • So farno plans to quit my day job

6
Taste Test at Dialysis
  • Cases of Protein Supplement arrive at the
    Dialysis unit ?
  • Pts get free Protein Supplement ?
  • Develop recipes
  • Track results

7
Taste and Texture
  • Most Pts found no taste / flavor
  • Strong odor from Whey Protein
  • Approx. 75 of pts who tried the product used it
    successfully
  • Reasons for drop-outs hospitalization or NH
    placement, disliked odor/ taste, didnt want to
    use any supplements, its just one more thing I
    dont want to do
  • Company decides to add vanilla (for scent)

8
OBSERVATIONAL RETROSPECTIVE
9
(No Transcript)
10
(No Transcript)
11
(No Transcript)
12
(No Transcript)
13
(No Transcript)
14
(No Transcript)
15
(No Transcript)
16
(No Transcript)
17
(No Transcript)
18
(No Transcript)
19
(No Transcript)
20
Controlled Studies Needed
  • Potential factors effecting results
  • pt compliance to Albumax dose
  • pt compliance to phosphate binders
  • hospitalizations (Albumax not available)
  • complications that reduce albumin
  • changes in prescribed binders/dose
  • dietary changes in phosphorus food intake
  • dietary changes in protein intake (up or down)

21
Conclusions
  • Albumax improved albumin levels by 10 compared
    to 3 for other proteins
  • Other Proteins increased phosphorus by 16
    compared to only 6 for Albumax

22
Questions?
Write a Comment
User Comments (0)
About PowerShow.com